Exact Mass: 654.426
Exact Mass Matches: 654.426
Found 156 metabolites which its exact mass value is equals to given mass value 654.426
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Notoginsenoside R9
Notoginsenoside R8 is found in tea. Notoginsenoside R8 is a constituent of Panax notoginseng (sanchi).
Ginsenoside M7cd
Ginsenoside M7cd is found in tea. Ginsenoside M7cd is isolated from ginseng. Isolated from ginseng. Ginsenoside M7cd is found in tea.
Momorcharaside B
Momorcharaside B is found in bitter gourd. Momorcharaside B is a constituent of Momordica charantia (bitter melon). Constituent of Momordica charantia (bitter melon). Momorcharaside B is found in bitter gourd and fruits.
PA(15:0/18:4(6Z,9Z,12Z,15Z))
PA(15:0/18:4(6Z,9Z,12Z,15Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(15:0/18:4(6Z,9Z,12Z,15Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of stearidonic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(18:4(6Z,9Z,12Z,15Z)/15:0)
PA(18:4(6Z,9Z,12Z,15Z)/15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:4(6Z,9Z,12Z,15Z)/15:0), in particular, consists of one chain of stearidonic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
Pseudoginsenoside RT5
Pseudoginsenoside RT5 is isolated from Panax quinquefolium[1]. Pseudoginsenoside RT5 is isolated from Panax quinquefolium[1].
(20S,24E)-3beta,6alpha,12beta,20beta,26-pentahydroxydammar-24-ene 20-O-beta-D-glucopyranoside|ginsenoside Km
1-(4,5-Dihydroxy-1,5-dimethylhexyl)-2,5-dihydroxy-3a,6,6,12a-tetramethyltetradecahydro-1H-cyclopenta[a]cyclopropa[e]phenanthren-7-yl hexopyranoside
(20S)-dammar-23(E)-ene-3beta,6alpha,12beta,20,25-pentol 6-O-beta-D-glucopyranoside|(20S)-ginsenoside ST2
3beta-D-glucopyranosyloxy-6alpha,16alpha,20(S),27-tetrahydroxydammar-24(Z)-ene|trilocularol A 3-glucoside
(20R)-3-O-beta-D-(2-O-methylxylopyranosyl)-24-propylcholest-4-ene-3beta,6beta,8,15alpha,16beta,24-hexaol|sanguinoside A
(20S)-2alpha,3beta,12beta,24(S)-pentahydroxydammar-25-ene 20-O-beta-glucopyranoside
(20S,23E)-3beta,12beta,20,25-tetrahydroxydammarane-23-ene 20-O-beta-D-glucopyranoside|ginsenoside Rh13
16-O-(beta-D-glucopyranosyl)-3beta,12beta,16beta,21alpha,22-pentahydroxy hopane|glinoside C
3beta,6alpha,12beta,24,25-pentahydroxydammar-20(22)(E)-ene-6-O-beta-D-glucopyranoside|notoginsenoside ST-1
(24R)-5alpha,6alpha-epoxycucurbit-3beta,11alpha,24,25-tetrol 3-O-beta-D-glucopyranoside|5alpha,6alpha-epoxymogroside I E1
(20R,22E,24R,25S)-3-O-(2,3,4-tri-O-methyl-beta-D-xylopyranosyl)-24-methyl-5alpha-cholest-22-ene-3beta,4beta,8beta,15alpha,26-hexol|sanguinoside C
(20S)-3beta,6alpha,7beta,20,27-pentahydroxy-dammar-24-ene 20-O-beta-D-glucopyranoside
PA(15:0/18:4(6Z,9Z,12Z,15Z))
PA(15:1(9Z)/18:3(6Z,9Z,12Z))
PA(15:1(9Z)/18:3(9Z,12Z,15Z))
PA(18:3(6Z,9Z,12Z)/15:1(9Z))
PA(18:3(9Z,12Z,15Z)/15:1(9Z))
PA(18:4(6Z,9Z,12Z,15Z)/15:0)
Momorcharaside B
Ginsenoside M7cd
Vinaginsenoside R10
Notoginsenoside R9
[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate
[1-nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoate
(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate
[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-phosphonooxypropyl] (Z)-heptadec-9-enoate
[1-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropyl] heptadecanoate
(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
[1-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-phosphonooxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
(1-pentadecanoyloxy-3-phosphonooxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate
[(2R)-1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate
[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-phosphonooxypropyl] (11E,14E)-heptadeca-11,14-dienoate
[1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (7E,10E,13E,16E)-icosa-7,10,13,16-tetraenoate
[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate
[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate
[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (E)-heptadec-7-enoate
[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (7E,10E,13E,16E)-docosa-7,10,13,16-tetraenoate
[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (7E,10E,13E,16E)-icosa-7,10,13,16-tetraenoate
[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate
[1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate
[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] heptadecanoate
[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] (6E,9E,12E)-octadeca-6,9,12-trienoate
[(2R)-1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (6E,9E,12E)-octadeca-6,9,12-trienoate
[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate
[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (7E,10E,13E,16E)-docosa-7,10,13,16-tetraenoate
(2r,3r,4s,5s,6r)-2-{[(1s,3r,6s,8r,10s,11s,12s,14s,15r,16r)-15-[(2r,5r)-5,6-dihydroxy-6-methylheptan-2-yl]-10,14-dihydroxy-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,3s,3as,3bs,5r,5as,6r,7s,9as,9br,11ar)-1-[(2r,3e,5r,6s)-7-hydroxy-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-7-{[(2s,3r,4s,5r)-3,4,5-trimethoxyoxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6-tetrol
(1r,2r,3s,3as,3bs,5r,7s,9ar,9br,11ar)-7-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-1-[(2r,5r,7s)-7-hydroxy-5-isopropyloctan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,3,3b,5-tetrol
(2s,3s,4s)-4-[(2s,5r,7s,8r,9s)-2-[(2r,2'r,3's,5s,5'r)-2-ethyl-5'-[(2s,3s,5r,6s)-6-hydroxy-3,5,6-trimethyloxan-2-yl]-3'-methyl-[2,2'-bioxolan]-5-yl]-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl]-3-methoxy-2-methylpentanoic acid
(2s,3r,4s,5s,6r)-2-{[(1s,3as,3br,5ar,7s,9ar,9br,11r,11ar)-11-hydroxy-3a-(hydroxymethyl)-1-[(2s,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3b,6,6,9a-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
4-{2-[2-ethyl-5'-(6-hydroxy-3,5,6-trimethyloxan-2-yl)-3'-methyl-[2,2'-bioxolan]-5-yl]-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl}-3-methoxy-2-methylpentanoic acid
(24s)-pseudoginsenosidert4
{"Ingredient_id": "HBIN004544","Ingredient_name": "(24s)-pseudoginsenosidert4","Alias": "NA","Ingredient_formula": "C36H62O10","Ingredient_Smile": "CC1(C(CCC2(C1C(CC3(C2CC(C4C3(CCC4C5(CCC(O5)C(C)(C)O)C)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C)O)C","Ingredient_weight": "654.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18012","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21633074","DrugBank_id": "NA"}
alexandroside i
{"Ingredient_id": "HBIN015119","Ingredient_name": "alexandroside i","Alias": "NA","Ingredient_formula": "C36H62O10","Ingredient_Smile": "CC(CCC(C(C)(C)O)O)C1C(CC2(C1(CCC34C2CC(C5C3(C4)CCC(C5(C)C)OC6C(C(C(C(O6)CO)O)O)O)O)C)C)O","Ingredient_weight": "654.87","OB_score": "NA","CAS_id": "156165-58-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7041","PubChem_id": "379058","DrugBank_id": "NA"}